| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 60 | 2024 | 481 | 11.330 |
Why?
|
| Pleural Effusion, Malignant | 24 | 2024 | 159 | 8.450 |
Why?
|
| Lung Neoplasms | 80 | 2024 | 12020 | 6.110 |
Why?
|
| Thoracentesis | 12 | 2024 | 72 | 4.220 |
Why?
|
| Airway Obstruction | 13 | 2018 | 273 | 3.980 |
Why?
|
| Solitary Pulmonary Nodule | 13 | 2022 | 125 | 3.720 |
Why?
|
| Mediastinum | 19 | 2024 | 276 | 3.480 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 28 | 2024 | 5565 | 3.440 |
Why?
|
| Pulmonary Medicine | 8 | 2023 | 42 | 3.340 |
Why?
|
| Endosonography | 22 | 2024 | 551 | 3.050 |
Why?
|
| Pleural Effusion | 9 | 2024 | 228 | 2.780 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 13 | 2024 | 166 | 2.630 |
Why?
|
| Lung | 22 | 2024 | 3289 | 2.480 |
Why?
|
| Lung Diseases | 14 | 2019 | 749 | 2.430 |
Why?
|
| Neoplasm Staging | 30 | 2024 | 13998 | 2.320 |
Why?
|
| Lymph Nodes | 20 | 2024 | 3070 | 1.860 |
Why?
|
| Thoracoscopy | 8 | 2024 | 103 | 1.790 |
Why?
|
| Periodicals as Topic | 5 | 2023 | 324 | 1.780 |
Why?
|
| Quality of Health Care | 4 | 2019 | 627 | 1.560 |
Why?
|
| Biopsy, Fine-Needle | 12 | 2021 | 687 | 1.520 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2024 | 236 | 1.460 |
Why?
|
| Stents | 7 | 2018 | 1003 | 1.430 |
Why?
|
| Probability | 5 | 2024 | 884 | 1.350 |
Why?
|
| Pneumonia | 8 | 2020 | 795 | 1.340 |
Why?
|
| Humans | 189 | 2024 | 270465 | 1.310 |
Why?
|
| Pneumonectomy | 6 | 2024 | 862 | 1.280 |
Why?
|
| Multiple Pulmonary Nodules | 5 | 2022 | 60 | 1.270 |
Why?
|
| Image-Guided Biopsy | 9 | 2021 | 336 | 1.230 |
Why?
|
| Mediastinal Neoplasms | 6 | 2024 | 427 | 1.220 |
Why?
|
| Respiratory Tract Infections | 5 | 2019 | 408 | 1.210 |
Why?
|
| Decision Support Techniques | 7 | 2024 | 603 | 1.180 |
Why?
|
| Pulmonologists | 2 | 2017 | 12 | 1.120 |
Why?
|
| Respiratory Function Tests | 5 | 2018 | 355 | 1.110 |
Why?
|
| Respiration, Artificial | 8 | 2019 | 582 | 1.100 |
Why?
|
| Lymphatic Metastasis | 15 | 2024 | 4956 | 1.090 |
Why?
|
| Granulation Tissue | 2 | 2019 | 26 | 1.060 |
Why?
|
| Pleural Diseases | 3 | 2023 | 57 | 1.040 |
Why?
|
| Guideline Adherence | 4 | 2019 | 627 | 1.020 |
Why?
|
| Catheters, Indwelling | 12 | 2024 | 383 | 1.010 |
Why?
|
| Biopsy, Needle | 11 | 2016 | 1376 | 1.000 |
Why?
|
| Dyspnea | 5 | 2018 | 420 | 0.980 |
Why?
|
| SEER Program | 7 | 2024 | 1049 | 0.940 |
Why?
|
| Pleurodesis | 10 | 2023 | 70 | 0.930 |
Why?
|
| Practice Patterns, Physicians' | 6 | 2021 | 1308 | 0.930 |
Why?
|
| Adenocarcinoma | 7 | 2024 | 7883 | 0.910 |
Why?
|
| Bronchial Fistula | 2 | 2023 | 37 | 0.890 |
Why?
|
| Retrospective Studies | 47 | 2024 | 39761 | 0.860 |
Why?
|
| Pneumonia, Bacterial | 3 | 2015 | 135 | 0.860 |
Why?
|
| Peer Review, Research | 1 | 2023 | 66 | 0.840 |
Why?
|
| Male | 91 | 2024 | 128118 | 0.840 |
Why?
|
| Cost-Benefit Analysis | 3 | 2024 | 964 | 0.830 |
Why?
|
| Tomography, X-Ray Computed | 25 | 2020 | 7785 | 0.830 |
Why?
|
| Registries | 11 | 2021 | 2203 | 0.820 |
Why?
|
| Aged | 70 | 2024 | 73153 | 0.800 |
Why?
|
| Anesthesia, General | 5 | 2022 | 221 | 0.790 |
Why?
|
| Pleura | 6 | 2022 | 130 | 0.790 |
Why?
|
| Drug-Eluting Stents | 2 | 2019 | 77 | 0.760 |
Why?
|
| Photochemotherapy | 4 | 2024 | 116 | 0.760 |
Why?
|
| Female | 89 | 2024 | 148658 | 0.760 |
Why?
|
| Needles | 3 | 2016 | 107 | 0.750 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2021 | 316 | 0.740 |
Why?
|
| Bronchial Neoplasms | 3 | 2015 | 82 | 0.720 |
Why?
|
| Quality of Life | 7 | 2018 | 4772 | 0.700 |
Why?
|
| Robotic Surgical Procedures | 3 | 2021 | 532 | 0.700 |
Why?
|
| Middle Aged | 66 | 2024 | 90080 | 0.700 |
Why?
|
| Sensitivity and Specificity | 13 | 2024 | 5160 | 0.690 |
Why?
|
| Patient Selection | 4 | 2021 | 2030 | 0.670 |
Why?
|
| Publication Bias | 1 | 2019 | 37 | 0.660 |
Why?
|
| Deep Sedation | 2 | 2017 | 20 | 0.660 |
Why?
|
| Peer Review | 1 | 2019 | 82 | 0.650 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 307 | 0.640 |
Why?
|
| Neoplasms | 9 | 2023 | 15897 | 0.640 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2020 | 5585 | 0.640 |
Why?
|
| Random Allocation | 2 | 2019 | 740 | 0.630 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 2018 | 40 | 0.630 |
Why?
|
| Rubulavirus | 1 | 2018 | 8 | 0.630 |
Why?
|
| Empyema | 1 | 2018 | 37 | 0.620 |
Why?
|
| Drainage | 8 | 2024 | 462 | 0.620 |
Why?
|
| Betacoronavirus | 2 | 2020 | 513 | 0.620 |
Why?
|
| Proportional Hazards Models | 6 | 2021 | 5092 | 0.600 |
Why?
|
| Conscious Sedation | 2 | 2015 | 105 | 0.590 |
Why?
|
| Mesothelioma | 1 | 2022 | 558 | 0.580 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 2395 | 0.580 |
Why?
|
| Cross Infection | 4 | 2009 | 547 | 0.580 |
Why?
|
| Trachea | 2 | 2019 | 296 | 0.580 |
Why?
|
| United States | 18 | 2024 | 15855 | 0.570 |
Why?
|
| Pandemics | 3 | 2021 | 1596 | 0.560 |
Why?
|
| Biopsy | 14 | 2024 | 3385 | 0.550 |
Why?
|
| Lymphadenopathy | 1 | 2017 | 94 | 0.540 |
Why?
|
| Risk Factors | 19 | 2022 | 17832 | 0.520 |
Why?
|
| Risk Assessment | 12 | 2020 | 6776 | 0.520 |
Why?
|
| Pulmonary Embolism | 3 | 2005 | 341 | 0.520 |
Why?
|
| Early Detection of Cancer | 5 | 2020 | 1340 | 0.520 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 624 | 0.520 |
Why?
|
| Bronchi | 6 | 2017 | 324 | 0.510 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 698 | 0.510 |
Why?
|
| Radiology, Interventional | 1 | 2016 | 142 | 0.500 |
Why?
|
| Pneumothorax | 4 | 2020 | 166 | 0.500 |
Why?
|
| Disease Management | 3 | 2021 | 1090 | 0.490 |
Why?
|
| Physicians | 2 | 2023 | 866 | 0.490 |
Why?
|
| Intensive Care Units | 4 | 2019 | 738 | 0.480 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 600 | 0.470 |
Why?
|
| Choice Behavior | 1 | 2016 | 206 | 0.470 |
Why?
|
| Neutropenia | 3 | 2015 | 1007 | 0.470 |
Why?
|
| Ablation Techniques | 1 | 2015 | 149 | 0.450 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 4357 | 0.450 |
Why?
|
| Aged, 80 and over | 25 | 2024 | 30934 | 0.440 |
Why?
|
| Multidetector Computed Tomography | 1 | 2014 | 148 | 0.440 |
Why?
|
| Predictive Value of Tests | 9 | 2021 | 4942 | 0.440 |
Why?
|
| Cohort Studies | 12 | 2023 | 9467 | 0.430 |
Why?
|
| Postoperative Complications | 7 | 2024 | 5675 | 0.430 |
Why?
|
| Sentinel Lymph Node Biopsy | 3 | 2015 | 1451 | 0.420 |
Why?
|
| Decision Trees | 2 | 2024 | 181 | 0.420 |
Why?
|
| Bronchoscopes | 3 | 2013 | 16 | 0.420 |
Why?
|
| Thoracic Surgery | 1 | 2017 | 280 | 0.410 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2012 | 268 | 0.410 |
Why?
|
| Internet | 1 | 2017 | 703 | 0.400 |
Why?
|
| Infection Control | 2 | 2005 | 276 | 0.400 |
Why?
|
| Empyema, Pleural | 2 | 2024 | 48 | 0.400 |
Why?
|
| Opportunistic Infections | 1 | 2013 | 233 | 0.400 |
Why?
|
| Quality Improvement | 1 | 2019 | 919 | 0.390 |
Why?
|
| Fluoroscopy | 4 | 2021 | 223 | 0.390 |
Why?
|
| Critical Pathways | 2 | 2024 | 160 | 0.390 |
Why?
|
| Respiratory Sounds | 2 | 2015 | 90 | 0.380 |
Why?
|
| Exudates and Transudates | 2 | 2022 | 57 | 0.380 |
Why?
|
| Pulmonary Atelectasis | 2 | 2022 | 51 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 4 | 2005 | 3162 | 0.370 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 517 | 0.360 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2010 | 20 | 0.360 |
Why?
|
| Multivariate Analysis | 7 | 2020 | 4323 | 0.360 |
Why?
|
| Logistic Models | 7 | 2020 | 3439 | 0.360 |
Why?
|
| Bronchial Diseases | 4 | 2014 | 46 | 0.360 |
Why?
|
| Surgeons | 1 | 2017 | 487 | 0.350 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2010 | 290 | 0.350 |
Why?
|
| Diagnosis, Differential | 11 | 2016 | 4830 | 0.350 |
Why?
|
| Induction Chemotherapy | 1 | 2013 | 670 | 0.350 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 2641 | 0.350 |
Why?
|
| Pulmonary Surgical Procedures | 2 | 2020 | 25 | 0.340 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2010 | 50 | 0.340 |
Why?
|
| Cryosurgery | 2 | 2024 | 196 | 0.340 |
Why?
|
| Positron-Emission Tomography | 8 | 2024 | 2196 | 0.330 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2013 | 678 | 0.330 |
Why?
|
| Evidence-Based Medicine | 3 | 2013 | 1037 | 0.330 |
Why?
|
| Treatment Outcome | 16 | 2024 | 33730 | 0.320 |
Why?
|
| Certification | 1 | 2010 | 109 | 0.320 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2024 | 162 | 0.320 |
Why?
|
| Prospective Studies | 17 | 2024 | 13376 | 0.320 |
Why?
|
| Anticoagulants | 3 | 2023 | 776 | 0.310 |
Why?
|
| Leukemia | 2 | 2014 | 1720 | 0.310 |
Why?
|
| Forced Expiratory Volume | 3 | 2024 | 327 | 0.300 |
Why?
|
| Cisplatin | 1 | 2015 | 2497 | 0.300 |
Why?
|
| Bayes Theorem | 3 | 2022 | 1058 | 0.300 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 229 | 0.300 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2013 | 796 | 0.300 |
Why?
|
| Positron Emission Tomography Computed Tomography | 5 | 2020 | 879 | 0.300 |
Why?
|
| Texas | 6 | 2019 | 6434 | 0.290 |
Why?
|
| Adult | 39 | 2021 | 81750 | 0.290 |
Why?
|
| Chest Tubes | 3 | 2024 | 118 | 0.280 |
Why?
|
| Laser Therapy | 2 | 2024 | 465 | 0.280 |
Why?
|
| ErbB Receptors | 2 | 2020 | 2376 | 0.260 |
Why?
|
| Remission Induction | 3 | 2019 | 3650 | 0.260 |
Why?
|
| Respiratory Tract Diseases | 2 | 2020 | 111 | 0.250 |
Why?
|
| Antineoplastic Agents | 7 | 2021 | 14622 | 0.250 |
Why?
|
| Prognosis | 8 | 2024 | 22477 | 0.250 |
Why?
|
| Consensus | 2 | 2020 | 1102 | 0.250 |
Why?
|
| Reproducibility of Results | 7 | 2020 | 6182 | 0.240 |
Why?
|
| Survival Rate | 8 | 2019 | 12513 | 0.240 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 3 | 2022 | 1061 | 0.240 |
Why?
|
| Neoplasm Metastasis | 4 | 2021 | 5308 | 0.240 |
Why?
|
| Recurrence | 3 | 2024 | 4877 | 0.240 |
Why?
|
| Gravitation | 1 | 2024 | 27 | 0.240 |
Why?
|
| Thromboembolism | 1 | 2005 | 150 | 0.230 |
Why?
|
| Hospitals, Community | 1 | 2004 | 81 | 0.230 |
Why?
|
| Drug Resistance, Microbial | 2 | 2003 | 242 | 0.230 |
Why?
|
| Markov Chains | 1 | 2024 | 185 | 0.230 |
Why?
|
| Tomography, Spiral Computed | 1 | 2004 | 128 | 0.230 |
Why?
|
| Carcinoma | 1 | 2015 | 2607 | 0.230 |
Why?
|
| Research Design | 2 | 2023 | 1573 | 0.220 |
Why?
|
| Pleural Cavity | 2 | 2014 | 26 | 0.220 |
Why?
|
| Incidence | 6 | 2020 | 5814 | 0.220 |
Why?
|
| Survival Analysis | 6 | 2021 | 9293 | 0.220 |
Why?
|
| Clinical Competence | 2 | 2010 | 1324 | 0.220 |
Why?
|
| Equipment Failure | 3 | 2016 | 196 | 0.220 |
Why?
|
| Laryngeal Masks | 2 | 2022 | 78 | 0.220 |
Why?
|
| Pulmonary Veins | 1 | 2005 | 180 | 0.220 |
Why?
|
| Carcinoid Tumor | 2 | 2020 | 278 | 0.220 |
Why?
|
| Radiography, Thoracic | 4 | 2020 | 478 | 0.220 |
Why?
|
| Lymphatic Diseases | 2 | 2015 | 127 | 0.220 |
Why?
|
| Models, Statistical | 2 | 2020 | 1185 | 0.220 |
Why?
|
| Deoxyribonucleases | 2 | 2024 | 55 | 0.220 |
Why?
|
| Angiography | 1 | 2004 | 350 | 0.210 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2023 | 47 | 0.210 |
Why?
|
| Hemoptysis | 2 | 2013 | 41 | 0.210 |
Why?
|
| Photosensitizing Agents | 1 | 2003 | 81 | 0.210 |
Why?
|
| Foreign Bodies | 2 | 2016 | 159 | 0.200 |
Why?
|
| Thoracotomy | 2 | 2019 | 218 | 0.200 |
Why?
|
| Checklist | 1 | 2023 | 128 | 0.200 |
Why?
|
| Mediastinal Diseases | 2 | 2013 | 59 | 0.200 |
Why?
|
| Health Care Costs | 2 | 2024 | 700 | 0.200 |
Why?
|
| Bronchogenic Cyst | 2 | 2013 | 21 | 0.200 |
Why?
|
| Reference Standards | 1 | 2023 | 368 | 0.200 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2019 | 7271 | 0.200 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2022 | 94 | 0.200 |
Why?
|
| Drug Therapy, Combination | 2 | 2004 | 2329 | 0.190 |
Why?
|
| Autopsy | 2 | 2018 | 168 | 0.190 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2018 | 417 | 0.190 |
Why?
|
| Catheterization | 2 | 2020 | 417 | 0.190 |
Why?
|
| Life Tables | 1 | 2021 | 122 | 0.190 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2001 | 10 | 0.190 |
Why?
|
| Computer-Assisted Instruction | 1 | 2001 | 88 | 0.190 |
Why?
|
| Medical History Taking | 2 | 2013 | 175 | 0.190 |
Why?
|
| Bronchoalveolar Lavage | 2 | 2016 | 55 | 0.190 |
Why?
|
| Benchmarking | 1 | 2023 | 278 | 0.190 |
Why?
|
| Ultrasonography | 5 | 2014 | 1932 | 0.190 |
Why?
|
| Device Removal | 3 | 2020 | 338 | 0.180 |
Why?
|
| Therapeutic Irrigation | 1 | 2020 | 92 | 0.180 |
Why?
|
| Young Adult | 13 | 2021 | 22149 | 0.180 |
Why?
|
| Equipment Design | 4 | 2021 | 1203 | 0.180 |
Why?
|
| Calibration | 1 | 2021 | 346 | 0.180 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 15198 | 0.180 |
Why?
|
| Physical Examination | 2 | 2013 | 303 | 0.170 |
Why?
|
| Ventilation | 1 | 2019 | 19 | 0.170 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 59 | 0.170 |
Why?
|
| Catheters | 1 | 2020 | 133 | 0.170 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 485 | 0.170 |
Why?
|
| Faculty, Medical | 1 | 2023 | 309 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2015 | 6256 | 0.170 |
Why?
|
| Retreatment | 1 | 2020 | 448 | 0.170 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2019 | 50 | 0.160 |
Why?
|
| Thyroid Neoplasms | 3 | 2020 | 1876 | 0.160 |
Why?
|
| Fibrinolytic Agents | 2 | 2024 | 293 | 0.160 |
Why?
|
| Parenchymal Tissue | 1 | 2018 | 9 | 0.160 |
Why?
|
| Radiosurgery | 2 | 2020 | 1385 | 0.160 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2020 | 210 | 0.160 |
Why?
|
| Causality | 1 | 2019 | 177 | 0.160 |
Why?
|
| Mediastinoscopy | 2 | 2019 | 33 | 0.160 |
Why?
|
| Hematologic Neoplasms | 3 | 2019 | 1948 | 0.160 |
Why?
|
| Operating Rooms | 1 | 2019 | 128 | 0.150 |
Why?
|
| Absorbable Implants | 1 | 2018 | 60 | 0.150 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 4956 | 0.150 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 288 | 0.150 |
Why?
|
| Anti-Infective Agents | 2 | 2019 | 466 | 0.150 |
Why?
|
| Drug Synergism | 1 | 2021 | 1359 | 0.150 |
Why?
|
| Pleurisy | 1 | 2017 | 12 | 0.150 |
Why?
|
| Debridement | 2 | 2013 | 119 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2020 | 336 | 0.150 |
Why?
|
| Swine | 2 | 2019 | 1607 | 0.150 |
Why?
|
| Tracheal Diseases | 2 | 2014 | 36 | 0.150 |
Why?
|
| Disease Progression | 2 | 2019 | 6828 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2020 | 221 | 0.150 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2022 | 1261 | 0.140 |
Why?
|
| Watchful Waiting | 1 | 2019 | 293 | 0.140 |
Why?
|
| Propofol | 1 | 2017 | 79 | 0.140 |
Why?
|
| Analysis of Variance | 1 | 2021 | 2321 | 0.140 |
Why?
|
| Blastomyces | 1 | 2016 | 9 | 0.140 |
Why?
|
| Blastomycosis | 1 | 2016 | 18 | 0.140 |
Why?
|
| Critical Care | 2 | 2020 | 803 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 325 | 0.140 |
Why?
|
| Algorithms | 4 | 2021 | 3919 | 0.140 |
Why?
|
| Pulmonary Emphysema | 2 | 2009 | 158 | 0.140 |
Why?
|
| Neutrophils | 1 | 2021 | 867 | 0.140 |
Why?
|
| Printing, Three-Dimensional | 1 | 2018 | 142 | 0.140 |
Why?
|
| Hemorrhage | 2 | 2019 | 724 | 0.140 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 373 | 0.140 |
Why?
|
| Electromagnetic Fields | 1 | 2016 | 54 | 0.130 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 216 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2020 | 392 | 0.130 |
Why?
|
| Prostheses and Implants | 2 | 2009 | 294 | 0.130 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 107 | 0.130 |
Why?
|
| Airway Extubation | 1 | 2017 | 74 | 0.130 |
Why?
|
| Software | 2 | 2019 | 1387 | 0.130 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 481 | 0.130 |
Why?
|
| Diaphragm | 1 | 2017 | 187 | 0.130 |
Why?
|
| Hypnotics and Sedatives | 1 | 2017 | 219 | 0.130 |
Why?
|
| Suction | 3 | 2024 | 122 | 0.130 |
Why?
|
| Prosthesis Design | 1 | 2018 | 655 | 0.130 |
Why?
|
| Ethical Analysis | 2 | 1986 | 53 | 0.130 |
Why?
|
| Forecasting | 1 | 2018 | 704 | 0.130 |
Why?
|
| Moral Obligations | 2 | 1986 | 85 | 0.120 |
Why?
|
| Respiratory Muscles | 1 | 1995 | 27 | 0.120 |
Why?
|
| User-Computer Interface | 3 | 2008 | 303 | 0.120 |
Why?
|
| Machine Learning | 1 | 2018 | 365 | 0.120 |
Why?
|
| Tracheitis | 1 | 2014 | 19 | 0.120 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2019 | 442 | 0.120 |
Why?
|
| Acute Disease | 3 | 2014 | 2493 | 0.120 |
Why?
|
| Hamartoma | 1 | 2015 | 121 | 0.120 |
Why?
|
| Radiology | 1 | 2019 | 428 | 0.120 |
Why?
|
| Voriconazole | 1 | 2014 | 115 | 0.120 |
Why?
|
| Granuloma | 1 | 2015 | 151 | 0.120 |
Why?
|
| Medicare | 1 | 2019 | 927 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 248 | 0.110 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 197 | 0.110 |
Why?
|
| Myositis | 1 | 1995 | 86 | 0.110 |
Why?
|
| Personal Autonomy | 2 | 1986 | 206 | 0.110 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2020 | 743 | 0.110 |
Why?
|
| Sarcoidosis | 1 | 1995 | 113 | 0.110 |
Why?
|
| Hypoalbuminemia | 1 | 2013 | 44 | 0.110 |
Why?
|
| Drug Resistance, Bacterial | 2 | 2009 | 423 | 0.110 |
Why?
|
| Truth Disclosure | 2 | 1986 | 179 | 0.110 |
Why?
|
| Comparative Effectiveness Research | 1 | 2014 | 120 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 1265 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 7010 | 0.110 |
Why?
|
| Guidelines as Topic | 2 | 2019 | 369 | 0.110 |
Why?
|
| Review Literature as Topic | 1 | 2013 | 83 | 0.110 |
Why?
|
| Length of Stay | 1 | 2019 | 2000 | 0.100 |
Why?
|
| Trace Elements | 1 | 2012 | 35 | 0.100 |
Why?
|
| Respiratory Aspiration | 1 | 2012 | 31 | 0.100 |
Why?
|
| Carcinoma, Small Cell | 2 | 2008 | 427 | 0.100 |
Why?
|
| Equipment and Supplies | 1 | 2012 | 50 | 0.100 |
Why?
|
| B7-H1 Antigen | 1 | 2019 | 1080 | 0.100 |
Why?
|
| Informed Consent | 2 | 1986 | 415 | 0.100 |
Why?
|
| Adolescent | 8 | 2021 | 32701 | 0.100 |
Why?
|
| Antifungal Agents | 3 | 2016 | 875 | 0.100 |
Why?
|
| Methylene Blue | 1 | 2012 | 52 | 0.100 |
Why?
|
| Asthma | 1 | 2020 | 894 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 1689 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2013 | 173 | 0.100 |
Why?
|
| Mucus | 1 | 2011 | 109 | 0.100 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2012 | 64 | 0.100 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 382 | 0.100 |
Why?
|
| Palliative Care | 3 | 2020 | 2172 | 0.100 |
Why?
|
| Time Factors | 4 | 2020 | 12996 | 0.100 |
Why?
|
| Patient Preference | 1 | 2013 | 229 | 0.090 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2003 | 211 | 0.090 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2010 | 38 | 0.090 |
Why?
|
| Foreign-Body Migration | 1 | 2011 | 122 | 0.090 |
Why?
|
| Pericardium | 1 | 2012 | 146 | 0.090 |
Why?
|
| Cytokines | 1 | 2020 | 2822 | 0.090 |
Why?
|
| Penicillin-Binding Proteins | 1 | 2010 | 15 | 0.090 |
Why?
|
| Ketoconazole | 1 | 1990 | 36 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2001 | 1441 | 0.090 |
Why?
|
| Food, Formulated | 1 | 1990 | 55 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 559 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2013 | 1075 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 261 | 0.090 |
Why?
|
| Diagnostic Imaging | 2 | 2013 | 1176 | 0.090 |
Why?
|
| Staphylococcus epidermidis | 1 | 2010 | 66 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 2016 | 1035 | 0.090 |
Why?
|
| Radiography, Interventional | 1 | 2012 | 311 | 0.090 |
Why?
|
| Necrosis | 3 | 2018 | 594 | 0.080 |
Why?
|
| Radionuclide Imaging | 1 | 2010 | 656 | 0.080 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2012 | 509 | 0.080 |
Why?
|
| Iron | 1 | 2012 | 380 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2018 | 1932 | 0.080 |
Why?
|
| Social Responsibility | 2 | 1986 | 92 | 0.080 |
Why?
|
| Ventilators, Mechanical | 1 | 2009 | 48 | 0.080 |
Why?
|
| Pulmonary Circulation | 2 | 2009 | 132 | 0.080 |
Why?
|
| Long-Term Care | 1 | 2009 | 84 | 0.080 |
Why?
|
| Single-Blind Method | 2 | 2024 | 416 | 0.080 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2008 | 20 | 0.080 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2008 | 48 | 0.080 |
Why?
|
| Quinazolines | 1 | 2013 | 956 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2013 | 608 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2012 | 560 | 0.080 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 870 | 0.080 |
Why?
|
| Aspergillosis | 1 | 1990 | 248 | 0.080 |
Why?
|
| Nursing Homes | 1 | 2009 | 100 | 0.080 |
Why?
|
| Linear Models | 1 | 2011 | 1096 | 0.080 |
Why?
|
| Drug Therapy | 1 | 2009 | 206 | 0.080 |
Why?
|
| DNA, Bacterial | 1 | 2010 | 597 | 0.080 |
Why?
|
| Sarcoma | 1 | 2018 | 1836 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2013 | 824 | 0.070 |
Why?
|
| Pseudomonas Infections | 1 | 2009 | 166 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 318 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 2355 | 0.070 |
Why?
|
| Osteomyelitis | 1 | 1990 | 258 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2008 | 163 | 0.070 |
Why?
|
| Mass Screening | 1 | 2015 | 1548 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2009 | 250 | 0.070 |
Why?
|
| ROC Curve | 1 | 2010 | 1249 | 0.070 |
Why?
|
| Lymphoma | 1 | 2015 | 1517 | 0.070 |
Why?
|
| Ethics | 1 | 1986 | 27 | 0.070 |
Why?
|
| Freedom | 1 | 1986 | 19 | 0.070 |
Why?
|
| Clinical Decision-Making | 2 | 2021 | 533 | 0.070 |
Why?
|
| Human Rights | 1 | 1986 | 25 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 9043 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 4960 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2018 | 3662 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 7370 | 0.060 |
Why?
|
| Intubation, Intratracheal | 2 | 2003 | 466 | 0.060 |
Why?
|
| Hospitals | 1 | 2009 | 489 | 0.060 |
Why?
|
| Mass Chest X-Ray | 1 | 2004 | 4 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 5923 | 0.060 |
Why?
|
| Netherlands | 1 | 2024 | 90 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 1082 | 0.060 |
Why?
|
| Patient Advocacy | 1 | 1984 | 90 | 0.060 |
Why?
|
| Patients | 1 | 1986 | 247 | 0.060 |
Why?
|
| Age Factors | 1 | 2013 | 5467 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 3471 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2005 | 310 | 0.060 |
Why?
|
| Itraconazole | 2 | 2016 | 81 | 0.060 |
Why?
|
| Australia | 1 | 2024 | 262 | 0.060 |
Why?
|
| Societies, Medical | 2 | 2023 | 1320 | 0.060 |
Why?
|
| Chest Pain | 1 | 2024 | 172 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2009 | 679 | 0.050 |
Why?
|
| Bronchography | 2 | 2013 | 24 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2005 | 235 | 0.050 |
Why?
|
| Canada | 1 | 2024 | 440 | 0.050 |
Why?
|
| Immunocompromised Host | 2 | 2019 | 717 | 0.050 |
Why?
|
| Patient Participation | 1 | 1986 | 456 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2003 | 311 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 335 | 0.050 |
Why?
|
| Program Development | 1 | 2003 | 262 | 0.050 |
Why?
|
| Positive-Pressure Respiration | 1 | 2022 | 124 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2009 | 920 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2003 | 234 | 0.050 |
Why?
|
| Melanoma | 1 | 1999 | 5595 | 0.050 |
Why?
|
| Ethics, Medical | 1 | 1984 | 437 | 0.050 |
Why?
|
| Observation | 1 | 2001 | 52 | 0.050 |
Why?
|
| Quality Control | 2 | 2012 | 463 | 0.050 |
Why?
|
| Ventilator Weaning | 1 | 2000 | 33 | 0.050 |
Why?
|
| Home Infusion Therapy | 1 | 2000 | 10 | 0.050 |
Why?
|
| Sclerosing Solutions | 1 | 2000 | 27 | 0.050 |
Why?
|
| Research | 1 | 2023 | 429 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2003 | 609 | 0.040 |
Why?
|
| Catheter Ablation | 1 | 2005 | 574 | 0.040 |
Why?
|
| Spirometry | 1 | 2020 | 153 | 0.040 |
Why?
|
| Carcinoma, Bronchogenic | 1 | 2000 | 35 | 0.040 |
Why?
|
| Patient Care Management | 1 | 2020 | 91 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2013 | 3148 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2020 | 6201 | 0.040 |
Why?
|
| Animals | 3 | 2020 | 61994 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 2912 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 424 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2007 | 3993 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2003 | 1066 | 0.040 |
Why?
|
| Bias | 1 | 2020 | 214 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2019 | 23 | 0.040 |
Why?
|
| Sleep Medicine Specialty | 1 | 2019 | 7 | 0.040 |
Why?
|
| Radiography | 2 | 2000 | 1989 | 0.040 |
Why?
|
| Decision Making | 1 | 1986 | 1251 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 2 | 2013 | 423 | 0.040 |
Why?
|
| Awareness | 1 | 2019 | 114 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2001 | 396 | 0.040 |
Why?
|
| Databases as Topic | 2 | 2009 | 138 | 0.040 |
Why?
|
| Lung Volume Measurements | 2 | 2009 | 97 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 135 | 0.040 |
Why?
|
| Mutation | 2 | 2020 | 15904 | 0.040 |
Why?
|
| Learning | 1 | 2001 | 433 | 0.040 |
Why?
|
| Fiducial Markers | 1 | 2018 | 95 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2020 | 2364 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 324 | 0.040 |
Why?
|
| Cell Transdifferentiation | 1 | 2018 | 114 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 16645 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2022 | 10384 | 0.030 |
Why?
|
| Communication | 1 | 2023 | 856 | 0.030 |
Why?
|
| Indazoles | 1 | 2018 | 310 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2021 | 597 | 0.030 |
Why?
|
| Tracheostomy | 1 | 2019 | 248 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2000 | 488 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2001 | 1573 | 0.030 |
Why?
|
| Hoarseness | 1 | 2016 | 25 | 0.030 |
Why?
|
| Fistula | 1 | 1996 | 76 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 2455 | 0.030 |
Why?
|
| Pleural Neoplasms | 1 | 2019 | 485 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 653 | 0.030 |
Why?
|
| Cryotherapy | 1 | 2014 | 67 | 0.030 |
Why?
|
| Smoking | 1 | 2003 | 2545 | 0.030 |
Why?
|
| Aspergillus | 1 | 2014 | 151 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2024 | 2452 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 2234 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2016 | 490 | 0.030 |
Why?
|
| Contraindications | 1 | 2013 | 154 | 0.030 |
Why?
|
| Steroids | 1 | 2014 | 369 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2019 | 1250 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 322 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 2061 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2017 | 2031 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 10694 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 548 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2015 | 1043 | 0.020 |
Why?
|
| Thoracostomy | 1 | 2010 | 47 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 2009 | 106 | 0.020 |
Why?
|
| Aspergillus fumigatus | 1 | 1990 | 136 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2015 | 773 | 0.020 |
Why?
|
| Amphotericin B | 1 | 1990 | 304 | 0.020 |
Why?
|
| Exercise Test | 1 | 2009 | 309 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2000 | 2388 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 7647 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2006 | 45 | 0.020 |
Why?
|
| Patient Safety | 1 | 2012 | 651 | 0.020 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 175 | 0.020 |
Why?
|
| Mental Competency | 1 | 1986 | 59 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2012 | 1553 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2006 | 106 | 0.020 |
Why?
|
| Inflammation | 1 | 2015 | 2510 | 0.020 |
Why?
|
| Attitude | 1 | 1986 | 162 | 0.020 |
Why?
|
| Patient Care | 1 | 1986 | 151 | 0.020 |
Why?
|
| Oxygen | 1 | 2009 | 793 | 0.020 |
Why?
|
| Paternalism | 1 | 1984 | 30 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 2475 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 2853 | 0.010 |
Why?
|
| Health Personnel | 1 | 2008 | 656 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2008 | 875 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 1986 | 740 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 4476 | 0.010 |
Why?
|
| Esophageal Neoplasms | 1 | 2013 | 3234 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 35572 | 0.010 |
Why?
|
| Child | 1 | 2013 | 30536 | 0.010 |
Why?
|